Xtant Medical Holdings, Inc.
XTNT
$0.54
-$0.01-1.47%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.21% | 16.88% | 15.16% | 20.81% | 28.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.21% | 16.88% | 15.16% | 20.81% | 28.44% |
| Cost of Revenue | 1.23% | 13.49% | 19.53% | 31.13% | 36.88% |
| Gross Profit | 23.54% | 19.06% | 12.44% | 14.34% | 22.99% |
| SG&A Expenses | -3.87% | -8.57% | -6.54% | 5.24% | 21.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.09% | -0.88% | 2.56% | 14.61% | 27.48% |
| Operating Income | 160.32% | 145.33% | 100.21% | 37.42% | -18.87% |
| Income Before Tax | 143.05% | 113.41% | 13.81% | -260.11% | -1,468.27% |
| Income Tax Expenses | 984.49% | -31.63% | 119.33% | 105.72% | 111.02% |
| Earnings from Continuing Operations | 130.23% | 109.96% | -37.44% | -621.54% | -2,592.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 130.23% | 109.96% | -37.44% | -621.54% | -2,592.42% |
| EBIT | 160.32% | 145.33% | 100.21% | 37.42% | -18.87% |
| EBITDA | 259.30% | 210.01% | 146.29% | 61.06% | -12.41% |
| EPS Basic | 129.60% | 111.44% | -27.76% | -476.00% | -40,100.00% |
| Normalized Basic EPS | 122.39% | 114.17% | 77.33% | 27.82% | -13.89% |
| EPS Diluted | 124.07% | 107.16% | -47.21% | -427.06% | -3,768.75% |
| Normalized Diluted EPS | 120.91% | 112.24% | 75.63% | 26.74% | -15.84% |
| Average Basic Shares Outstanding | 0.74% | 9.66% | 10.24% | 13.16% | 16.36% |
| Average Diluted Shares Outstanding | 7.03% | 14.26% | 11.23% | 12.32% | 14.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |